2020 年 2 月至 3 月，意大利佛罗伦萨传染病和热带病科在冠状病毒病（COVID-19）大流行期间的早期经验。
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.
机构信息
Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Infectious and Tropical Diseases Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy.
出版信息
Euro Surveill. 2020 Apr;25(17). doi: 10.2807/1560-7917.ES.2020.25.17.2000556.
Abstract
We analysed the first 84 coronavirus disease (COVID-19) patients hospitalised in an infectious and tropical disease unit in Florence, Italy, over 30 days after the start of the COVID-19 outbreak in Italy. A 12% reduction in the rate of intensive care unit transfer was observed after the implementation of intensity care measures in the regular ward such as increasing the nurse/patient ratio, presence of critical care physicians and using high flow nasal cannulae oxygenation.
摘要
我们分析了意大利佛罗伦萨传染病和热带病科在意大利 COVID-19 爆发后 30 天内收治的前 84 例 COVID-19 患者。在普通病房实施了强化护理措施（如增加护士/患者比例、配备重症监护医生和使用高流量鼻导管吸氧）后，重症监护病房的转院率降低了 12%。
相似文献
1
Early experience of an infectious and tropical diseases unit during the coronavirus disease (COVID-19) pandemic, Florence, Italy, February to March 2020.
Euro Surveill. 2020 Apr;25(17). doi: 10.2807/1560-7917.ES.2020.25.17.2000556.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Setup of a Dedicated Coronavirus Intensive Care Unit: Logistical Aspects.
Anesthesiology. 2020 Jul;133(1):244-246. doi: 10.1097/ALN.0000000000003325.
4
Regional COVID-19 Network for Coordination of SARS-CoV-2 outbreak in Veneto, Italy.
J Cardiothorac Vasc Anesth. 2020 Sep;34(9):2341-2345. doi: 10.1053/j.jvca.2020.05.005. Epub 2020 May 15.
5
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection.
Infect Dis (Lond). 2020 Oct;52(10):698-704. doi: 10.1080/23744235.2020.1784457. Epub 2020 Jun 25.
6
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
7
Age-specific SARS-CoV-2 infection fatality ratio and associated risk factors, Italy, February to April 2020.
Euro Surveill. 2020 Aug;25(31). doi: 10.2807/1560-7917.ES.2020.25.31.2001383.
8
Mortality impacts of the coronavirus disease (COVID-19) outbreak by sex and age: rapid mortality surveillance system, Italy, 1 February to 18 April 2020.
Euro Surveill. 2020 May;25(19). doi: 10.2807/1560-7917.ES.2020.25.19.2000620.
9
Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study.
Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620963016. doi: 10.1177/1753466620963016.
10
Intensive care for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in a makeshift ICU in Wuhan.
Crit Care. 2020 May 6;24(1):199. doi: 10.1186/s13054-020-02914-6.
引用本文的文献
1
Taste loss as a distinct symptom of COVID-19: a systematic review and meta-analysis.
Chem Senses. 2023 Jan 1;48. doi: 10.1093/chemse/bjad043.
2
Effects of the pre-existing coronary heart disease on the prognosis of COVID-19 patients: A systematic review and meta-analysis.
PLoS One. 2023 Oct 10;18(10):e0292021. doi: 10.1371/journal.pone.0292021. eCollection 2023.
3
High-Flow Nasal Oxygen and Noninvasive Ventilation for COVID-19.
Crit Care Clin. 2022 Jul;38(3):601-621. doi: 10.1016/j.ccc.2022.01.006. Epub 2022 Jan 10.
4
Associations of pre-existing cardiovascular morbidity with severity and the fatality rate in COVID-19 patients: a systematic review and meta-analysis.
Osong Public Health Res Perspect. 2022 Feb;13(1):37-50. doi: 10.24171/j.phrp.2021.0186. Epub 2022 Feb 18.
5
Host Factor Interaction Networks Identified by Integrative Bioinformatics Analysis Reveals Therapeutic Implications in COPD Patients With COVID-19.
Front Pharmacol. 2021 Dec 23;12:718874. doi: 10.3389/fphar.2021.718874. eCollection 2021.
6
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion.
Semin Immunol. 2021 Jun;55:101508. doi: 10.1016/j.smim.2021.101508. Epub 2021 Oct 26.
7
The Effects of Previous Asthma and COPD on the Susceptibility to and Severity of COVID-19: A Nationwide Cohort Study in South Korea.
J Clin Med. 2021 Oct 9;10(20):4626. doi: 10.3390/jcm10204626.
8
Impact of metabolic and cardiovascular disease on COVID-19 mortality: A systematic review and meta-analysis.
Diabetes Metab Syndr. 2021 Nov-Dec;15(6):102308. doi: 10.1016/j.dsx.2021.102308. Epub 2021 Oct 6.
9
Taste loss as a distinct symptom of COVID-19: A systematic review and meta-analysis.
medRxiv. 2021 Oct 9:2021.10.09.21264771. doi: 10.1101/2021.10.09.21264771.
10
Chronic Diseases as a Predictor for Severity and Mortality of COVID-19: A Systematic Review With Cumulative Meta-Analysis.
Front Med (Lausanne). 2021 Sep 1;8:588013. doi: 10.3389/fmed.2021.588013. eCollection 2021.
本文引用的文献
1
Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study.
Eur Arch Otorhinolaryngol. 2020 Aug;277(8):2251-2261. doi: 10.1007/s00405-020-05965-1. Epub 2020 Apr 6.
2
Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Cross-sectional Study.
Clin Infect Dis. 2020 Jul 28;71(15):889-890. doi: 10.1093/cid/ciaa330.
3
Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy.
JAMA. 2020 May 12;323(18):1775-1776. doi: 10.1001/jama.2020.4683.
4
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia.
Emerg Microbes Infect. 2020 Dec;9(1):727-732. doi: 10.1080/22221751.2020.1746199.
5
COVID-19: consider cytokine storm syndromes and immunosuppression.
Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
6
On the use of corticosteroids for 2019-nCoV pneumonia.
Lancet. 2020 Feb 29;395(10225):683-684. doi: 10.1016/S0140-6736(20)30361-5. Epub 2020 Feb 12.
7
Clinical Characteristics of Coronavirus Disease 2019 in China.
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
Zotero 插件